William H. Hind
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen-glucose deprivation via PPAR? and 5-HT1A
Hind, William H.; England, Timothy J.; O'Sullivan, Saoirse E.
Authors
Professor Tim England Timothy.England@nottingham.ac.uk
PROFESSOR OF STROKE MEDICINE
Saoirse E. O'Sullivan
Abstract
Background and Purpose: In vivo and in vitro studies have demonstrated a protective effect of cannabidiol (CBD) in reducing infarct size in stroke models and against epithelial barrier damage in numerous disease models. We aimed to investigate whether CBD also affects blood–brain barrier (BBB) permeability following ischaemia.
Experimental Approach: Human brain microvascular endothelial cell (HBMEC) and human astrocyte co‐cultures modelled the BBB. Ischaemia was modelled by oxygen–glucose deprivation (OGD) and permeability was measured by transepithelial electrical resistance.
Key Results: CBD (10 μM) prevented the increase in permeability caused by 4 h OGD. CBD was most effective when administered before the OGD, but protective effects were observed up to 2 h into reperfusion. This protective effect was inhibited by a PPARγ antagonist and partly reduced by a 5‐HT1A receptor antagonist, but was unaffected by antagonists of cannabinoid CB1 or CB2 receptors, TRPV1 channels or adenosine A2A receptors. CBD also reduced cell damage, as measured by LDH release and by markers of cellular adhesion, such as the adhesion molecule VCAM‐1. In HBMEC monocultures, CBD decreased VCAM‐1 and increased VEGF levels, effects which were inhibited by PPARγ antagonism.
Conclusions and Implications: These data suggest that preventing permeability changes at the BBB could represent an as yet unrecognized mechanism of CBD‐induced neuroprotection in ischaemic stroke, a mechanism mediated by activation of PPARγ and 5‐HT1A receptors.
Citation
Hind, W. H., England, T. J., & O'Sullivan, S. E. (2016). Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen-glucose deprivation via PPARγ and 5-HT1A. British Journal of Pharmacology, 173(5), 815-825. https://doi.org/10.1111/bph.13368
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 13, 2015 |
Online Publication Date | Oct 24, 2015 |
Publication Date | Mar 1, 2016 |
Deposit Date | Sep 13, 2018 |
Print ISSN | 0007-1188 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 173 |
Issue | 5 |
Pages | 815-825 |
DOI | https://doi.org/10.1111/bph.13368 |
Public URL | https://nottingham-repository.worktribe.com/output/1106192 |
Publisher URL | https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.13368 |
You might also like
Remote Ischemic Conditioning for Secondary Stroke Prevention: Time for a Clinical Trial?
(2024)
Journal Article
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia
(2023)
Journal Article
Remote ischemic conditioning for stroke: A critical systematic review
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search